An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management
Open accessThe DOI matches its Crossref record; 324 of the 325 references it cites were found in a registry or an index.
Abstract
This document is an international evidence-based guideline on the diagnosis and management of idiopathic pulmonary fibrosis, and is a collaborative effort of the American Thoracic Society, the European Respiratory Society, the Japanese Respiratory Society, and the Latin American Thoracic Association. It represents the current state of knowledge regarding idiopathic pulmonary fibrosis (IPF), and contains sections on definition and epidemiology, risk factors, diagnosis, natural history, staging and prognosis, treatment, and monitoring disease course. For the diagnosis and treatment sections, pragmatic GRADE evidence-based methodology was applied in a question-based format. For each diagnosis and treatment question, the committee graded the quality of the evidence available (high, moderate, low, or very low), and made a recommendation (yes or no, strong or weak). Recommendations were based on majority vote. It is emphasized that clinicians must spend adequate time with patients to discuss patients' values and preferences and decide on the appropriate course of action.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, all patients originally gathered from hospital register using ICD-10 codes were meticulously re-assessed and re-classified using the year 2011 criteria, and the cases representing some other type of ILDs were excluded [14].”
From Comparison of disease progression subgroups in idiopathic pulmonary fibrosis (2019) · cites this paper as [14]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“ILD still has a poor prognosis and the highest mortality rate during lung transplantation.”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [48]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Interstitial lung disease (ILD) remains an important indication for lung transplantation, and the number of patients with this disease is increasing.”
From Indications for Lung Transplantation and Patient Selection (2022) · cites this paper as [48]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Idiopathic pulmonary fibrosis (IPF), characterized histopathologically and/or radiologically with a usual interstitial pneumonia (UIP) pattern, is the most common adult form of interstitial pneumonia of unknown origin [1].”
From Lung transplantation in idiopathic pulmonary fibrosis: a systematic review of the literature (2014) · cites this paper as [1]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The median survival time for patients with IPF is 2 to 3 years from diagnosis and the 5-year survival rate ranges between 30% and 50% [1,5-7].”
From Lung transplantation in idiopathic pulmonary fibrosis: a systematic review of the literature (2014) · cites this paper as [1]
Experimental — accuracy not yet measured
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Miller, M. R., Hankinson, J., Brusasco, V., Burgos, F., Casaburi, R., Coates, A., Crapo, R., Enright, P., van der Grinten, C. P. M., Gustafsson, P., et al. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00034805 · Cited by 15,627
ATS Statement: Guidelines for the Six-Minute Walk Test
(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.166.1.at1102 · Cited by 11,195
Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., & Thun, M. J. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.1.43 · Cited by 7,439
Interpretative strategies for lung function tests
Pellegrino, R., Viegi, G., Brusasco, V., Crapo, R. O., Burgos, F., Casaburi, R., Coates, A., van der Grinten, C. P. M., Gustafsson, P., Hankinson, J., et al. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00035205 · Cited by 5,945
Fleischner Society: Glossary of Terms for Thoracic Imaging
Hansell, D. M., Bankier, A. A., MacMahon, H., McLoud, T. C., Müller, N. L., & Remy, J. (2008) · Radiology · doi:10.1148/radiol.2462070712 · Cited by 4,198
Self-citation(2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.165.2.ats01 · Cited by 4,196
Standardisation of the measurement of lung volumes
Wanger, J., Clausen, J. L., Coates, A., Pedersen, O. F., Brusasco, V., Burgos, F., Casaburi, R., Crapo, R., Enright, P., van der Grinten, C. P. M., et al. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00035005 · Cited by 2,768
Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment: International Consensus Statement
(2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.2.ats3-00 · Cited by 2,628
Standardisation of the single-breath determination of carbon monoxide uptake in the lung
MacIntyre, N., Crapo, R. O., Viegi, G., Johnson, D. C., van der Grinten, C. P. M., Brusasco, V., Burgos, F., Casaburi, R., Coates, A., Enright, P., et al. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00034905 · Cited by 2,255
NOCTURNAL OXYGEN THERAPY TRIAL GROUP* (1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-3-391 · Cited by 2,218
Research works printed but not linked: 9
- Cochrane Handbook for Systematic Reviews of Interventions 5.0.2. Oxford: The Cochrane Collaboration, 2009. [online] 2009. [accessed 20 June 2010]; Available from: http://www.cochrane.org/resources/handbook/.
- Nadrous HF, Ryu JH, Douglas WW, Decker PA, Olson EJ. Impact of angiotensin-converting enzyme inhibitors and statins on survival in idiopathic pulmonary fibrosis. Chest 2004;126:438–446. [DOI] [PubMed] [Google Scholar]
- 2005, J Gastrointest Surg, 1053
- Marshall RP, Puddicombe A, Cookson WO, Laurent GJ. Adult familial cryptogenic fibrosing alveolitis in the UK. Thorax 2000;55:143–146. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gross TJ, Hunninghake GW. Idiopathic pulmonary fibrosis. N Engl J Med 2001;345:517–525. [DOI] [PubMed] [Google Scholar]
- Kondo A, Saiki S. Acute exacerbation in idiopathic interstitial pneumonia (IIP). In: Harasawa M, Fukuchi Y, Morinari H, editors. Interstitial pneumonia of unknown etiology. Tokyo: University of Tokyo Press; 1989. pp. 33–42.
- Flaherty KR, Colby TV, Toews GB, Travis WD, Flint A, Gay SE, Strawderman RL III, Jain A, Lynch JP III, Martinez FJ. Differential presence of fibroblastic foci in UIP patients with or without conntective tissue disease. Am J Respir Crit Care Med 2001;163:A983. [Google Scholar]
- Molina-Molina M, Badia JR, Marin-Arguedas A, Xaubet A, Santos MJ, Nicolas JM, Ferrer M, Torres A. Outcomes and clinical characteristics of patients with pulmonary fibrosis and respiratory failure admitted to an intensive care unit: a study of 20 cases. Med Clin (Barc) 2003;121:63–67. [DOI] [PubMed] [Google Scholar]
- Pitsiou G, Ioannis Trigonis I, Tsiata E, Kontou P, Manolakoglou N, Stanopoulos I, Mavrofridis E, Argyropoulou P. Outcome of patients with pulmonary fibrosis admitted to the ICU for acute respiratory failure. Eur Respir J Suppl 2006;28:E650. [Google Scholar]
Cited by
Items 201–300 of 1,060
Host–Microbial Interactions in Idiopathic Pulmonary Fibrosis
Molyneaux, P. L., Willis-Owen, S. A. G., Cox, M. J., James, P., Cowman, S., Loebinger, M., Blanchard, A., Edwards, L. M., Stock, C., Daccord, C., et al. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201607-1408oc · Cited by 217
Self-citationZhou, Y., Peng, H., Sun, H., Peng, X., Tang, C., Gan, Y., Chen, X., Mathur, A., Hu, B., Slade, M. D., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007096 · Cited by 215
Safety and pharmacokinetics of nintedanib and pirfenidone in idiopathic pulmonary fibrosis
Ogura, T., Taniguchi, H., Azuma, A., Inoue, Y., Kondoh, Y., Hasegawa, Y., Bando, M., Abe, S., Mochizuki, Y., Chida, K., et al. (2015) · European Respiratory Journal · doi:10.1183/09031936.00198013 · Cited by 215
Self-citationIncreasing Global Mortality from Idiopathic Pulmonary Fibrosis in the Twenty-First Century
Hutchinson, J. P., McKeever, T. M., Fogarty, A. W., Navaratnam, V., & Hubbard, R. B. (2014) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201404-145oc · Cited by 214
Md Yusof, M. Y., Kabia, A., Darby, M., Lettieri, G., Beirne, P., Vital, E. M., Dass, S., & Emery, P. (2017) · Rheumatology · doi:10.1093/rheumatology/kex072 · Cited by 214
Salisbury, M. L., Gu, T., Murray, S., Gross, B. H., Chughtai, A., Sayyouh, M., Kazerooni, E. A., Myers, J. L., Lagstein, A., Konopka, K. E., et al. (2019) · Chest · doi:10.1016/j.chest.2018.08.1076 · Cited by 213
Self-citationLong term respiratory complications of covid-19
Fraser, E. (2020) · BMJ · doi:10.1136/bmj.m3001 · Cited by 213
Clinical Pharmacokinetics and Pharmacodynamics of Nintedanib
Wind, S., Schmid, U., Freiwald, M., Marzin, K., Lotz, R., Ebner, T., Stopfer, P., & Dallinger, C. (2019) · Clinical Pharmacokinetics · doi:10.1007/s40262-019-00766-0 · Cited by 212
Kreuter, M., Swigris, J., Pittrow, D., Geier, S., Klotsche, J., Prasse, A., Wirtz, H., Koschel, D., Andreas, S., Claussen, M., et al. (2017) · Respiratory Research · doi:10.1186/s12931-017-0621-y · Cited by 210
Self-citationMesothelial cells in tissue repair and fibrosis
Mutsaers, S. E., Birnie, K., Lansley, S., Herrick, S. E., Lim, C.-B., & Prêle, C. M. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00113 · Cited by 210
Finnerty, J. P., Ponnuswamy, A., Dutta, P., Abdelaziz, A., & Kamil, H. (2021) · BMC Pulmonary Medicine · doi:10.1186/s12890-021-01783-1 · Cited by 209
Barriers to timely diagnosis of interstitial lung disease in the real world: the INTENSITY survey
Cosgrove, G. P., Bianchi, P., Danese, S., & Lederer, D. J. (2018) · BMC Pulmonary Medicine · doi:10.1186/s12890-017-0560-x · Cited by 208
The importance of interventional timing in the bleomycin model of pulmonary fibrosis
Kolb, P., Upagupta, C., Vierhout, M., Ayaub, E., Bellaye, P. S., Gauldie, J., Shimbori, C., Inman, M., Ask, K., & Kolb, M. R. J. (2020) · European Respiratory Journal · doi:10.1183/13993003.01105-2019 · Cited by 208
Viral Infection Increases the Risk of Idiopathic Pulmonary Fibrosis
Sheng, G., Chen, P., Wei, Y., Yue, H., Chu, J., Zhao, J., Wang, Y., Zhang, W., & Zhang, H.-L. (2020) · Chest · doi:10.1016/j.chest.2019.10.032 · Cited by 208
Collard, H. R., Yow, E., Richeldi, L., Anstrom, K. J., Glazer, C., & for the IPFnet investigators (2013) · Respiratory Research · doi:10.1186/1465-9921-14-73 · Cited by 207
Self-citationExploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPF
Mercer, P. F., Woodcock, H. V., Eley, J. D., Platé, M., Sulikowski, M. G., Durrenberger, P. F., Franklin, L., Nanthakumar, C. B., Man, Y., Genovese, F., et al. (2016) · Thorax · doi:10.1136/thoraxjnl-2015-207429 · Cited by 206
Self-citationAmnion Epithelial Cell-Derived Exosomes Restrict Lung Injury and Enhance Endogenous Lung Repair
Tan, J. L., Lau, S. N., Leaw, B., Nguyen, H. P. T., Salamonsen, L. A., Saad, M. I., Chan, S. T., Zhu, D., Krause, M., Kim, C., et al. (2018) · Stem Cells Translational Medicine · doi:10.1002/sctm.17-0185 · Cited by 206
Pirfenidone Reduces Respiratory-related Hospitalizations in Idiopathic Pulmonary Fibrosis
Ley, B., Swigris, J., Day, B.-M., Stauffer, J. L., Raimundo, K., Chou, W., & Collard, H. R. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201701-0091oc · Cited by 206
Self-citationAcute exacerbation of idiopathic pulmonary fibrosis: shifting the paradigm
Ryerson, C. J., Cottin, V., Brown, K. K., & Collard, H. R. (2015) · European Respiratory Journal · doi:10.1183/13993003.00419-2015 · Cited by 205
Self-citationPrasse, A., Binder, H., Schupp, J. C., Kayser, G., Bargagli, E., Jaeger, B., Hess, M., Rittinghausen, S., Vuga, L., Lynn, H., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201712-2551oc · Cited by 204
Lung Fibroblasts, Aging, and Idiopathic Pulmonary Fibrosis
Pardo, A., & Selman, M. (2016) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201605-341aw · Cited by 204
Self-citationMacrophage Activation in Acute Exacerbation of Idiopathic Pulmonary Fibrosis
Schupp, J. C., Binder, H., Jäger, B., Cillis, G., Zissel, G., Müller-Quernheim, J., & Prasse, A. (2015) · PLOS ONE · doi:10.1371/journal.pone.0116775 · Cited by 204
Thalidomide for the Treatment of Cough in Idiopathic Pulmonary Fibrosis: A Randomized Trial
Horton, M. R., Santopietro, V., Mathew, L., Horton, K. M., Polito, A. J., Liu, M. C., Danoff, S. K., & Lechtzin, N. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-6-201209180-00003 · Cited by 204
Palmer, S. M., Snyder, L., Todd, J. L., Soule, B., Christian, R., Anstrom, K., Luo, Y., Gagnon, R., & Rosen, G. (2018) · Chest · doi:10.1016/j.chest.2018.08.1058 · Cited by 202
Role of atmospheric pollution on the natural history of idiopathic pulmonary fibrosis
Sesé, L., Nunes, H., Cottin, V., Sanyal, S., Didier, M., Carton, Z., Israel-Biet, D., Crestani, B., Cadranel, J., Wallaert, B., et al. (2018) · Thorax · doi:10.1136/thoraxjnl-2017-209967 · Cited by 202
Hou, J., Shi, J., Chen, L., Lv, Z., Chen, X., Cao, H., Xiang, Z., & Han, X. (2018) · Cell Communication and Signaling · doi:10.1186/s12964-018-0300-8 · Cited by 202
Sex and Gender Differences in Lung Disease
Silveyra, P., Fuentes, N., & Bauza, D. E. R. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-68748-9_14 · Cited by 202
de Christenson, M. L. R. (2012) · Yearbook of Diagnostic Radiology · doi:10.1016/j.yrad.2012.03.015 · Cited by 202
Baseline KL-6 predicts increased risk for acute exacerbation of idiopathic pulmonary fibrosis
Ohshimo, S., Ishikawa, N., Horimasu, Y., Hattori, N., Hirohashi, N., Tanigawa, K., Kohno, N., Bonella, F., Guzman, J., & Costabel, U. (2014) · Respiratory Medicine · doi:10.1016/j.rmed.2014.04.009 · Cited by 201
Self-citationOlson, A. L., Gifford, A. H., Inase, N., Fernández Pérez, E. R., & Suda, T. (2018) · European Respiratory Review · doi:10.1183/16000617.0077-2018 · Cited by 200
Behr, J., Prasse, A., Wirtz, H., Koschel, D., Pittrow, D., Held, M., Klotsche, J., Andreas, S., Claussen, M., Grohé, C., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.02279-2019 · Cited by 198
Self-citationPredicting outcomes in idiopathic pulmonary fibrosis using automated computed tomographic analysis
Jacob, J., Bartholmai, B. J., Rajagopalan, S., van Moorsel, C. H. M., van Es, H. W., van Beek, F. T., Struik, M. H. L., Kokosi, M., Egashira, R., Brun, A. L., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201711-2174oc · Cited by 198
Self-citationDiabetes and Lung Disease: An Underestimated Relationship
Khateeb, J., Fuchs, E., & Khamaisi, M. (2019) · Review of Diabetic Studies · doi:10.1900/rds.2019.15.1 · Cited by 198
Xu, J., Xu, X., Jiang, L., Dua, K., Hansbro, P. M., & Liu, G. (2020) · Respiratory Research · doi:10.1186/s12931-020-01445-6 · Cited by 198
Computed Tomography: Revolutionizing the Practice of Medicine for 40 Years
Rubin, G. D. (2014) · Radiology · doi:10.1148/radiol.14141356 · Cited by 197
Time for a change: is idiopathic pulmonary fibrosis still idiopathic and only fibrotic?
Wolters, P. J., Blackwell, T. S., Eickelberg, O., Loyd, J. E., Kaminski, N., Jenkins, G., Maher, T. M., Molina-Molina, M., Noble, P. W., Raghu, G., et al. (2018) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30007-9 · Cited by 196
Self-citationRare Variants in RTEL1 Are Associated with Familial Interstitial Pneumonia
Cogan, J. D., Kropski, J. A., Zhao, M., Mitchell, D. B., Rives, L., Markin, C., Garnett, E. T., Montgomery, K. H., Mason, W. R., McKean, D. F., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201408-1510oc · Cited by 196
Self-citationDressen, A., Abbas, A. R., Cabanski, C., Reeder, J., Ramalingam, T. R., Neighbors, M., Bhangale, T. R., Brauer, M. J., Hunkapiller, J., Reeder, J., et al. (2018) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(18)30135-8 · Cited by 196
Self-citationZinellu, A., Collu, C., Nasser, M., Paliogiannis, P., Mellino, S., Zinellu, E., Traclet, J., Ahmad, K., Mangoni, A. A., Carru, C., et al. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10184134 · Cited by 196
Davidson, K. R., Ha, D. M., Schwarz, M. I., & Chan, E. D. (2020) · Journal of Thoracic Disease · doi:10.21037/jtd-20-651 · Cited by 196
Predictors of mortality in rheumatoid arthritis‐related interstitial lung disease
Assayag, D., Lubin, M., Lee, J. S., King, T. E., Collard, H. R., & Ryerson, C. J. (2014) · Respirology · doi:10.1111/resp.12234 · Cited by 195
Self-citationPaterniti, M. O., Bi, Y., Rekić, D., Wang, Y., Karimi-Shah, B. A., & Chowdhury, B. A. (2017) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201606-458oc · Cited by 194
Jacob, J., Bartholmai, B. J., Rajagopalan, S., Kokosi, M., Nair, A., Karwoski, R., Raghunath, S. M., Walsh, S. L. F., Wells, A. U., & Hansell, D. M. (2016) · Journal of Thoracic Imaging · doi:10.1097/rti.0000000000000220 · Cited by 194
Self-citationLuppi, F., Kalluri, M., Faverio, P., Kreuter, M., & Ferrara, G. (2021) · Respiratory Research · doi:10.1186/s12931-021-01711-1 · Cited by 194
Zhang, J., Wang, D., Wang, L., Wang, S., Roden, A. C., Zhao, H., Li, X., Prakash, Y. S., Matteson, E. L., Tschumperlin, D. J., et al. (2019) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00301.2018 · Cited by 194
Herzog, E. L., Mathur, A., Tager, A. M., Feghali‐Bostwick, C., Schneider, F., & Varga, J. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38702 · Cited by 193
Idiopathic Pulmonary Fibrosis – Diagnosis and Treatment
Bendstrup, E. (2014) · General Medicine: Open Access · doi:10.4172/2327-5146.1000161 · Cited by 192
Natural history of idiopathic pulmonary fibrosis
Kim, H. J., Perlman, D., & Tomic, R. (2015) · Respiratory Medicine · doi:10.1016/j.rmed.2015.02.002 · Cited by 191
Current Biomedical Use of Copper Chelation Therapy
Baldari, S., Di Rocco, G., & Toietta, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21031069 · Cited by 191
Kahloon, R. A., Xue, J., Bhargava, A., Csizmadia, E., Otterbein, L., Kass, D. J., Bon, J., Soejima, M., Levesque, M. C., Lindell, K. O., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201203-0506oc · Cited by 190
Shulgina, L., Cahn, A. P., Chilvers, E. R., Parfrey, H., Clark, A. B., Wilson, E. C. F., Twentyman, O. P., Davison, A. G., Curtin, J. J., Crawford, M. B., et al. (2013) · Thorax · doi:10.1136/thoraxjnl-2012-202403 · Cited by 190
Changes in the respiratory microbiome during acute exacerbations of idiopathic pulmonary fibrosis
Molyneaux, P. L., Cox, M. J., Wells, A. U., Kim, H. C., Ji, W., Cookson, W. O. C., Moffatt, M. F., Kim, D. S., & Maher, T. M. (2017) · Respiratory Research · doi:10.1186/s12931-017-0511-3 · Cited by 190
Self-citationHansen, D., Dendale, P., Coninx, K., Vanhees, L., Piepoli, M. F., Niebauer, J., Cornelissen, V., Pedretti, R., Geurts, E., Ruiz, G. R., et al. (2017) · European Journal of Preventive Cardiology · doi:10.1177/2047487317702042 · Cited by 189
Hansell, D. M., Goldin, J. G., King, T. E., Lynch, D. A., Richeldi, L., & Wells, A. U. (2015) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(15)00096-x · Cited by 189
Self-citationHumphries, S. M., Yagihashi, K., Huckleberry, J., Rho, B.-H., Schroeder, J. D., Strand, M., Schwarz, M. I., Flaherty, K. R., Kazerooni, E. A., van Beek, E. J. R., et al. (2017) · Radiology · doi:10.1148/radiol.2017161177 · Cited by 188
Self-citationRomero, Y., Bueno, M., Ramirez, R., Álvarez, D., Sembrat, J. C., Goncharova, E. A., Rojas, M., Selman, M., Mora, A. L., & Pardo, A. (2016) · Aging Cell · doi:10.1111/acel.12514 · Cited by 188
Self-citationLi, X., Zhang, T., Lv, W., Wang, H., Chen, H., Xu, Q., Cai, H., & Dai, J. (2022) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2022.113238 · Cited by 188
Anti-MDA5 Antibodies in a Large Mediterranean Population of Adults with Dermatomyositis
Labrador-Horrillo, M., Martinez, M. A., Selva-O'Callaghan, A., Trallero-Araguas, E., Balada, E., Vilardell-Tarres, M., & Juárez, C. (2014) · Journal of Immunology Research · doi:10.1155/2014/290797 · Cited by 188
Kadota, T., Fujita, Y., Araya, J., Watanabe, N., Fujimoto, S., Kawamoto, H., Minagawa, S., Hara, H., Ohtsuka, T., Yamamoto, Y., et al. (2021) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12124 · Cited by 187
Romagnoli, M., Colby, T. V., Berthet, J.-P., Gamez, A. S., Mallet, J.-P., Serre, I., Cancellieri, A., Cavazza, A., Solovei, L., Dell’Amore, A., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201810-1947oc · Cited by 187
Self-citationThe Toll-like Receptor 3 L412F Polymorphism and Disease Progression in Idiopathic Pulmonary Fibrosis
O’Dwyer, D. N., Armstrong, M. E., Trujillo, G., Cooke, G., Keane, M. P., Fallon, P. G., Simpson, A. J., Millar, A. B., McGrath, E. E., Whyte, M. K., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201304-0760oc · Cited by 186
Drug Treatment of Idiopathic Pulmonary Fibrosis
Canestaro, W. J., Forrester, S. H., Raghu, G., Ho, L., & Devine, B. E. (2016) · Chest · doi:10.1016/j.chest.2015.11.013 · Cited by 186
Self-citationIdiopathic pulmonary fibrosis: effects and optimal management of comorbidities
King, C. S., & Nathan, S. D. (2017) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(16)30222-3 · Cited by 186
Raghu, G., Lynch, D., Godwin, J. D., Webb, R., Colby, T. V., Leslie, K. O., Behr, J., Brown, K. K., Egan, J. J., Flaherty, K. R., et al. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70011-6 · Cited by 186
Self-citationEffects of inpatient pulmonary rehabilitation in patients with interstitial lung disease
Huppmann, P., Sczepanski, B., Boensch, M., Winterkamp, S., Schönheit-Kenn, U., Neurohr, C., Behr, J., & Kenn, K. (2013) · European Respiratory Journal · doi:10.1183/09031936.00081512 · Cited by 186
Self-citationHambly, N., Farooqi, M. M., Dvorkin-Gheva, A., Donohoe, K., Garlick, K., Scallan, C., Chong, S. G., MacIsaac, S., Assayag, D., Johannson, K. A., et al. (2022) · European Respiratory Journal · doi:10.1183/13993003.02571-2021 · Cited by 186
Self-citationRelative versus absolute change in forced vital capacity in idiopathic pulmonary fibrosis
Richeldi, L., Ryerson, C. J., Lee, J. S., Wolters, P. J., Koth, L. L., Ley, B., Elicker, B. M., Jones, K. D., King, T. E., Ryu, J. H., et al. (2012) · Thorax · doi:10.1136/thoraxjnl-2011-201184 · Cited by 185
Self-citationRaghu, G., & Selman, M. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201411-2044ed · Cited by 185
Self-citation‘WNT-er is coming’: WNT signalling in chronic lung diseases
Baarsma, H. A., & Königshoff, M. (2017) · Thorax · doi:10.1136/thoraxjnl-2016-209753 · Cited by 185
Prognostic Factors for Myositis-Associated Interstitial Lung Disease
Fujisawa, T., Hozumi, H., Kono, M., Enomoto, N., Hashimoto, D., Nakamura, Y., Inui, N., Yokomura, K., Koshimizu, N., Toyoshima, M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098824 · Cited by 185
Flaherty, K. R., Brown, K. K., Wells, A. U., Clerisme-Beaty, E., Collard, H. R., Cottin, V., Devaraj, A., Inoue, Y., Le Maulf, F., Richeldi, L., et al. (2017) · BMJ Open Respiratory Research · doi:10.1136/bmjresp-2017-000212 · Cited by 184
Self-citationPrevalence and characteristics of TERT and TERC mutations in suspected genetic pulmonary fibrosis
Borie, R., Tabèze, L., Thabut, G., Nunes, H., Cottin, V., Marchand-Adam, S., Prevot, G., Tazi, A., Cadranel, J., Mal, H., et al. (2016) · European Respiratory Journal · doi:10.1183/13993003.02115-2015 · Cited by 184
Self-citationRomero-Bueno, F., Diaz del Campo, P., Trallero-Araguás, E., Ruiz-Rodríguez, J. C., Castellvi, I., Rodriguez-Nieto, M. J., Martínez-Becerra, M. J., Sanchez-Pernaute, O., Pinal-Fernandez, I., Solanich, X., et al. (2020) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2020.03.007 · Cited by 184
Ueki, N., Matsuo, Y., Togashi, Y., Kubo, T., Shibuya, K., Iizuka, Y., Mizowaki, T., Togashi, K., Mishima, M., & Hiraoka, M. (2014) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000359 · Cited by 184
A Novel Genomic Signature with Translational Significance for Human Idiopathic Pulmonary Fibrosis
Bauer, Y., Tedrow, J., de Bernard, S., Birker-Robaczewska, M., Gibson, K. F., Guardela, B. J., Hess, P., Klenk, A., Lindell, K. O., Poirey, S., et al. (2015) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2013-0310oc · Cited by 182
Cellular and Molecular Mechanisms of Chronic Inflammation-Associated Organ Fibrosis
Ueha, S., Shand, F. H. W., & Matsushima, K. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00071 · Cited by 182
Acute exacerbations of progressive-fibrosing interstitial lung diseases
Kolb, M., Bondue, B., Pesci, A., Miyazaki, Y., Song, J. W., Bhatt, N. Y., Huggins, J. T., Oldham, J. M., Padilla, M. L., Roman, J., et al. (2018) · European Respiratory Review · doi:10.1183/16000617.0071-2018 · Cited by 182
WNT/β-Catenin Signaling Induces IL-1β Expression by Alveolar Epithelial Cells in Pulmonary Fibrosis
Aumiller, V., Balsara, N., Wilhelm, J., Günther, A., & Königshoff, M. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2012-0524oc · Cited by 181
Epidemiology and survival of idiopathic pulmonary fibrosis from national data in Canada
Hopkins, R. B., Burke, N., Fell, C., Dion, G., & Kolb, M. (2016) · European Respiratory Journal · doi:10.1183/13993003.01504-2015 · Cited by 181
Acute exacerbations and pulmonary hypertension in advanced idiopathic pulmonary fibrosis
Judge, E. P., Fabre, A., Adamali, H. I., & Egan, J. J. (2012) · European Respiratory Journal · doi:10.1183/09031936.00115511 · Cited by 181
Self-citationOxygen therapy for interstitial lung disease: a systematic review
Bell, E. C., Cox, N. S., Goh, N., Glaspole, I., Westall, G. P., Watson, A., & Holland, A. E. (2017) · European Respiratory Review · doi:10.1183/16000617.0080-2016 · Cited by 181
Hozumi, H., Nakamura, Y., Johkoh, T., Sumikawa, H., Colby, T. V., Kono, M., Hashimoto, D., Enomoto, N., Fujisawa, T., Inui, N., et al. (2013) · BMJ Open · doi:10.1136/bmjopen-2013-003132 · Cited by 181
Self-citationMeng, Y., Yu, C.-H., Li, W., Li, T., Luo, W., Huang, S., Wu, P.-S., Cai, S.-X., & Li, X. (2014) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2012-0451oc · Cited by 181
Effect of nintedanib in subgroups of idiopathic pulmonary fibrosis by diagnostic criteria
Raghu, G., Wells, A. U., Nicholson, A. G., Richeldi, L., Flaherty, K. R., Le Maulf, F., Stowasser, S., Schlenker-Herceg, R., & Hansell, D. M. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201602-0402oc · Cited by 180
Self-citationWhite, E. S., Xia, M., Murray, S., Dyal, R., Flaherty, C. M., Flaherty, K. R., Moore, B. B., Cheng, L., Doyle, T. J., Villalba, J., et al. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201505-0862oc · Cited by 180
Self-citationNathan, S. D., Albera, C., Bradford, W. Z., Costabel, U., du Bois, R. M., Fagan, E. A., Fishman, R. S., Glaspole, I., Glassberg, M. K., Glasscock, K. F., et al. (2016) · Thorax · doi:10.1136/thoraxjnl-2015-207011 · Cited by 180
Self-citationHow does comorbidity influence survival in idiopathic pulmonary fibrosis?
Hyldgaard, C., Hilberg, O., & Bendstrup, E. (2014) · Respiratory Medicine · doi:10.1016/j.rmed.2014.01.008 · Cited by 180
Metabolic Profiling Regarding Pathogenesis of Idiopathic Pulmonary Fibrosis
Kang, Y. P., Lee, S. B., Lee, J.-M., Kim, H. M., Hong, J. Y., Lee, W. J., Choi, C. W., Shin, H. K., Kim, D.-J., Koh, E. S., et al. (2016) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6b00156 · Cited by 179
Self-citationQuantitative Computed Tomography Imaging of Interstitial Lung Diseases
Bartholmai, B. J., Raghunath, S., Karwoski, R. A., Moua, T., Rajagopalan, S., Maldonado, F., Decker, P. A., & Robb, R. A. (2013) · Journal of Thoracic Imaging · doi:10.1097/rti.0b013e3182a21969 · Cited by 179
High levels of IL-6 and IL-8 characterize early-on idiopathic pulmonary fibrosis acute exacerbations
Papiris, S. A., Tomos, I. P., Karakatsani, A., Spathis, A., Korbila, I., Analitis, A., Kolilekas, L., Kagouridis, K., Loukides, S., Karakitsos, P., et al. (2018) · Cytokine · doi:10.1016/j.cyto.2017.08.019 · Cited by 179
Predicting outcomes in rheumatoid arthritis related interstitial lung disease
Jacob, J., Hirani, N., van Moorsel, C. H. M., Rajagopalan, S., Murchison, J. T., van Es, H. W., Bartholmai, B. J., van Beek, F. T., Struik, M. H. L., Stewart, G. A., et al. (2019) · European Respiratory Journal · doi:10.1183/13993003.00869-2018 · Cited by 179
Self-citationRole of microRNAs in Lung Development and Pulmonary Diseases
Sessa, R., & Hata, A. (2013) · Pulmonary Circulation · doi:10.4103/2045-8932.114758 · Cited by 179
Kristensen, M. S., Teoh, W. H., Graumann, O., & Laursen, C. B. (2014) · Insights into Imaging · doi:10.1007/s13244-014-0309-5 · Cited by 179
Daily home spirometry: an effective tool for detecting progression in idiopathic pulmonary fibrosis
Russell, A.-M., Adamali, H., Molyneaux, P. L., Lukey, P. T., Marshall, R. P., Renzoni, E. A., Wells, A. U., & Maher, T. M. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201511-2152oc · Cited by 178
Self-citationLiu, Y., Lu, F., Kang, L., Wang, Z., & Wang, Y. (2017) · BMC Pulmonary Medicine · doi:10.1186/s12890-017-0405-7 · Cited by 178
Velcro crackles: the key for early diagnosis of idiopathic pulmonary fibrosis?
Cottin, V., & Cordier, J.-F. (2012) · European Respiratory Journal · doi:10.1183/09031936.00001612 · Cited by 178
Self-citationThe role of tyrosine kinases in the pathogenesis of idiopathic pulmonary fibrosis
Grimminger, F., Günther, A., & Vancheri, C. (2015) · European Respiratory Journal · doi:10.1183/09031936.00149614 · Cited by 178
Song, X., Cao, G., Jing, L., Lin, S., Wang, X., Zhang, J., Wang, M., Liu, W., & Lv, C. (2014) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12243 · Cited by 178
Diagnosis and management of interstitial lung disease
Meyer, K. C. (2014) · Translational Respiratory Medicine · doi:10.1186/2213-0802-2-4 · Cited by 177
Neumann, I., Santesso, N., Akl, E. A., Rind, D. M., Vandvik, P. O., Alonso-Coello, P., Agoritsas, T., Mustafa, R. A., Alexander, P. E., Schünemann, H., et al. (2016) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2015.11.017 · Cited by 177
Self-citation
Metadata
- Authors
- Raghu, G., Collard, H. R., Egan, J. J., Martinez, F. J., Behr, J., Brown, K. K., Colby, T. V., Cordier, J.-F., Flaherty, K. R., Lasky, J. A., Lynch, D. A., Ryu, J. H., Swigris, J. J., Wells, A. U., Ancochea, J., Bouros, D., Carvalho, C., Costabel, U., Ebina, M., Hansell, D. M., Johkoh, T., Kim, D. S., King, T. E., Kondoh, Y., Myers, J., Müller, N. L., Nicholson, A. G., Richeldi, L., Selman, M., Dudden, R. F., Griss, B. S., Protzko, S. L., & Schünemann, H. J.
- Affiliations
- University of Washington (US)
- University of California, San Francisco (US)
- Mater Misericordiae University Hospital (IE)
- Ludwig-Maximilians-Universität München (DE)
- Mayo Clinic (US)
- University of Michigan (US)
- Tulane University (US)
- University of Colorado Boulder (US)
- National Jewish Health (US)
- Royal Brompton Hospital (GB)
- Hospital Universitario de La Princesa (ES)
- University Hospital of Alexandroupolis (GR)
- Universidade de São Paulo (BR)
- Tohoku University (JP)
- Royal Brompton & Harefield NHS Foundation Trust (GB)
- The University of Osaka (JP)
- University of Ulsan (KR)
- University of Modena and Reggio Emilia (IT)
- Instituto Nacional de Enfermedades Respiratorias (MX)
- ORCID
- Raghu, Ganesh
- Collard, Harold R.
- Colby, Thomas V.
- Lasky, Joseph A.
- Lynch, David A.
- Ryu, Jay H.
- Swigris, Jeffrey J.
- Wells, Athol U.
- Ancochea, Julio
- Bouros, Demosthenes
- Carvalho, Carlos
- Costabel, Ulrich
- Johkoh, Takeshi
- King, Talmadge E.
- Kondoh, Yasuhiro
- Myers, Jeffrey
- Nicholson, Andrew G.
- Richeldi, Luca
- Selman, Moisés
- Schünemann, Holger J.
- Venue
- American Journal of Respiratory and Critical Care Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-03
- Volume
- 183
- Issue
- 6
- Pages
- 788-824
- ISSN
- 1073-449X (ISSN-L)
- 1535-4970
- PMC
- PMC5450933
- OpenAlex
- W2167383172
- Cited by
- 7,186
- References
- 325
- Citations by year
- 2026: 187 · 2025: 307 · 2024: 436 · 2023: 432 · 2022: 522 · 2021: 640 · 2020: 607 · 2019: 596 · 2018: 607 · 2017: 605 · 2016: 569 · 2015: 531 · 2014: 426 · 2013: 370 · 2012: 256
- FWCI
- 304.18
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- American Journal of Respiratory and Critical Care Medicine (publishedVersion, public-domain)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- ePrints Soton (University of Southampton) (submittedVersion)
- IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion, cc-by)
- Funders
- National Heart, Lung, and Blood Institute (K23HL092227)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
- Keywords
- idiopathic pulmonary fibrosis, diagnosis, management, natural history (disease), staging, prognosis, risk factors, treatment, disease surveillance, GRADE
- MeSH terms
- Europe, Humans, International Cooperation, Japan, Latin America, Societies, Medical, United States, Evidence-Based Medicine, Idiopathic Pulmonary Fibrosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.